A new enzymatic method for assaying iron in serum samples, suitable for automated analyzers, is reported. Three reagent mixtures are used: dilution buffer (pH 3.0; ascorbate), reagent 1 (pH 6.7; apoaconitase), and reagent 2 (pH 7.7; citrate, magnesium, and isocitrate dehydrogenase). Sera are diluted with dilution buffer. Fe3 is liberated from transferrin in sera under acidic conditions, and then reduced by ascorbate. Reagent 1 is added to diluted specimens, and apoaconitase is reactivated by Fe2 at neutral pH. The resulting solutionsare mixed with reagent 2, so that holoaconitase hydrolyzes citrate to isocitrate and the isocitrate and NADP are converted to 2-oxoglutarate, NADPH, and CO2. Serum iron is determined linearly up to 70 p.mol/L, with within-run CVs 2.4% and day-to-day CVs 2.9%. This method (y) givesresultscorrelatingwith those of a Reference Method 
Indexing Terms: aconitase/apoenzyme/holoenzyme/transferrin/ inte,'method comparison
In human serum, most iron is bound to transferrin, a carrier protein for iron (1). The concentration of iron in serum is a useful index for diagnosis of various anemias and liver diseases (2). Matsubara (3) reported a method for assaying serum iron, using bathophenanthroline as the iron-binding chromogen. The International Committee for Standardization in Haematology (ICSH) proposed a Reference Method with bathophenanthroline sulfonate (4)2 Later, they proposed the deproteinization of serum specimens before assay to improve accuracy (5) and, in 1990, proposed replacing the chromogen with ferrozine or ferene, which were more sensitive and cheaper, and reducing the volume of the specimens from 2.0 to 0.5 mL (6). These methods all involved manual procedures, which were too complicated to be practiced routinely in dinical laboratories. Received June 1, 1993; accepted January 8, 1994 .
However, bilirubin, always present at different concentrations in sera, introduced error into these methods involving iron chromogens.
We report here a new enzymatic rate assay of serum iron with automated analyzers. 
2-oxoglutarate
The overall reaction for the assay is thus:
The serum iron in the specimen can be determined by measuring the production of NAI)PH.
MaterIals and Methods Apparatus
We used the Model 7150 automated analyzer from Hitachi (Tokyo, Japan; also known as the Hitachi 717). In some cases, a conventional spectrophotometer (Model UV-2100S; Shimadzu Seisakusho, Kyoto, Japan) was also used.
Reagents

Chemicals.
We 
Assay Procedure
Serum specimens for assay were diluted fourfold with dilution buffer in the sample cups of the Hitachi automated analyzer and then incubated at room temperature for 5 mm. The analyzer then added 20 &L of the diluted specimens and 100 &L of reagent 1 to the reaction cells, and incubated these for 5 mm before adding 90 tL of reagent 2 to each. For the reagent blank, isotonic saline (9 gIL NaC1) was substituted for the specimens. Absorbance at 340 nm (A) was measured for each reaction mixture and corrected for the reagent blank. The reaction rate (AJmin) was measured 3-4 mm after addition of reagent 2 at analyzer settings of kinetic assay mode. The concentrations of iron in serum specimens were estimated on the calibration curve, produced with the iron calibrator solutions (0-70 moI/L). 
Results
Optimization Studies
Type and pH of buffer for reagent 2. We examined the effects on aconitase activity of various kinds and pH values of buffers in reagent 2: triethanolamine-HC1
(50 mmol/L, pH 6.0-8.0 at 25#{176}C), PIPES-NaOH (50 mmol/L, pH 7.0-9.0 at 25#{176}C), and Tris-HC1 (50 mmoIJL, pH 6.5-9.5 at 25#{176}C). Activities were maximum at pH 7.5-8.0 in the first two buffers, and at pH 7.5-8.5 with the last one.
Although Tris-HC1 showed the greatest activity at -pH 8, we chose to use PIPES at pH 7.7, which showed the least effect of temperature change on pH. pK/#{176}Cwas -0.0085 for PIPES-NaOH, -0.020 for triethanolamine-HC1, and -0.028 for Tris-HC1 (11, 12) .
Effects of citrate concentrations on rate. We examined the effects of citrate concentrations on the rate of the overall reaction.
Using a 20 mo1/L iron calibrator as the specimen, we followed the assay procedure as de- (Fig. 1) . It also increased with increasing concentrations of iron (Fe2). The increase was practically linear for Fe2 up to 200 mol/L at pH 6.3 and 6.5, up to 100 junol/L at pH 6.7, and up to 60 molJL at pH 6.9. We used pH 6.7 for reagent 1.
Assay Evaluation
Kinetics of reaction and linearity. We examined the kinetics of the overall reaction and the linearity of our method. Fig. 2 shows the results for assaying the iron calibrators (0-100 mol/L) and the time courses for the rates of the overall reaction. There was a lag phase for 3 mm after addition of reagent 2, whereas the reaction for iron concentrations up to 70 mol/L. Detection limit. We examined the detection limit of our method by assaying the 0 standard (9 g/L NaC1) 10 times. The result (mean ± SD) was 0.15 ± 0.31 mol/L.
The detection limit, defined as the mean iron concentration of the 0 standard + 2.6 SD, was therefore 0.96 1z.mol/L.
Precision. To examine the precision of our method we assayed two pooled human serum specimens containing different concentrations of iron. Within-run CVs for samples reassayed 20 times in the same assay were 2.4% (iron concentration, Analytical recovely. We exrniiined the recovery of serum iron by our method by adding various concentrations of iron to two pooled serum specimens and assaying. The analytical recoveriesof added iron were 100-103% (Table 3) .
Interference. We eyamined potential interferences in this assay of serum iron. A pooled serum specimen was supplemented with various cations and anions, ascorbate, bilirubin, lipids, and hemoglobin at concentrations significantly higher than the normal values (13): The resulting solutions were then assayed by our method and by the ICSH-proposed Reference Method (Table 4) .
Our results were hardly influenced by all the substances tested, except that NaC1 and CuSO4 caused negative errors of -7% at concentrations as great as 0.45 mol/L 
102
Calculatedfrom the dilution factors for theadded iron calibrator solution.
b Measuredminus added.
and 60 pmol/L, respectively.
Hemoglobin showed no effect at 16 prnol/L. The ICSH method (5), however, was slightly affected by 60 mo1/L CuSO4 and 16 moI/L hemoglobin.
Method comparison.
We examined the correlation between our method (y) and the ICSH method (x) for serum specimens containing <30 mgfL hemoglobin (5)
obtained from 72 patients (Fig. 3) . 
Discussion
Transferrin has a molecular mass of 77 kI)a (15), and is capable of strongly binding 2 mol of iron per mole (1).
In serum, -30% of transferrin is bound with iron. In transferrinemia, the concentration of serum iron is extremely low (16) , indicating that the iron is mostly bound to transferrin in either normal or abnormal sera.
In clinical diagnosis, one must be able to measure iron concentrations of sera lower than the normal value. Various methods for assaying serum iron with bathophenanthroline (3), bathophenanthroline sulfonate (4, 5), ferrozine, ferene (6), or nitroso-PSAP (7, 8) as the iron chromogen have been reported. The first two methods require large specimens (0.5-2.0 mL) and are difficult to automate, and the nitroso-PSAP method is affected by bilirubin.
After detailed optimization studies, we developed a new enzymatic method that determines concentration of serum iron. Intact aconitase is bound with 4 mol of iron per mole (17). The enzyme, if treated with appropriate iron-chelatingreagent,is easily inactivated.
The inactivated apoenzyme becomes reactivated when incubated with Fe2. Almost all the iron in the serum is bound to transferrin (1). Ferritransferrin releases Fe3 at acidic pH, whereas apotransferrin binds it at neutral and alkaline pH (18). When we mixed serum specimens with a dilution buffer of acetate (pH 3) and ascorbate, the ferritransferrin present rapidly released all the Fe3 (Eq. 1). Given that the reducing ability of ascorbate is high at neutral and alkaline pH but low at acidic pH, we supplemented mixtures of serum specimens and dilution buffer with reagent 1 (containing PIPES-NaOH, pH 6.7, and apoaconitase), so that the ascorbate could reduce all the Fe3 to Fe2 (Eq. 2). Simultaneously, the inactive apoenzyme was bound to Fe2 and reactivated (Eq. 3). When the resulting solutions were further supplemented with reagent 2 (containing PIPES-NaOH, pH 7.7, citrate, Mg2, NADP and lCD), the reactivated holoenzyme catalyzed the hydrolysis of citrate to isocitrate (Eq. 4), which was followed by the conversion of isocitrate and NADP to 2-oxoglutarate and NADPH (Eq. 5). The rates for reduction of NADP in our method were proportional to the concentrations of serum iron in the specimens.
In summary, our new enzymatic rate assay of serum iron is suitable for use with automated analyzers. Highly specific for serum iron, this method is safe and is not affected by other cations, bilirubin, or lipemia. The detection limit of <1 moI/L demonstrates that this is a highly sensitive method. The mean values of iron concentration measured in serum specimens from healthy subjects by our method generally agree with earlier reports with the ICSH method (19). Because our method is simple, accurate, and sensitive, we conclude it may be useful in routine clinical diagnosis with automated analyzers.
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